55 patients representing 17 cancer types tested positive for TRK fusion and were treated with larotrectinib. Overall response rate was 75 percent.
from Top Health News – ScienceDaily http://bit.ly/2oqOHD7
from Tumblr http://bit.ly/2oqVUmX
55 patients representing 17 cancer types tested positive for TRK fusion and were treated with larotrectinib. Overall response rate was 75 percent.
No comments:
Post a Comment